Although the therapeutic use of induced fever has attracted the eagerattention of ophthalmologists, it is certain that it is far from having entered into the current domain of ophthalmology. Works treating the question are still rare, especially in French-speaking countries. Among the authors who have occupied themselves with this matter may be cited: in Belgium, J. Francois; in France, J. P. Carlotti, A. Gault, D. Paulian, S. Schiff-Wertheimer and H. Viallefont ; in the United States, W. L. Benedict, G. P. Clark, A. M. Culler and W. M. Simpson, P. O'Leary and A. L. Welsh, C. Weskamp, and E. L. Whitney; in Italy, A. Ferrari, Livio-Pratti, G. Roasenda, Sabbadini, and G. Tirelli; in Rumania, L. Winkler ; in Germany, C. Behr. Fischer and Ascher, B. Fleischer, Gasteiger, R. Hessberg, Igersheimer, E. Weinberg, and J. Wolff, in Austria, Wagner-Jauregg, and in Japan, K. Ohyama.
Before indicating the pyretogenic processes that are made
HAMBRESIN L. PYRETOTHERAPY IN OPHTHALMOLOGY. Arch Ophthalmol. 1938;19(4):497–514. doi:10.1001/archopht.1938.00850160023002
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: